Evidence map›Paper›PMID 35164028›Full record

ArticleMolecules (Basel, Switzerland)2022

Quantitative Analysis of Abamectin, Albendazole, Levamisole HCl and Closantel in Q-DRENCH Oral Suspension Using a Stability-Indicating HPLC-DAD Method.

Hazim M Ali, Mohammed Gamal, Mohammed M Ghoneim, Lobna Mohammed Abd Elhalim

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Hazim M AliDepartment of Chemistry, College of Science, Jouf University, P.O. Box 2014, Sakaka 72388, Aljouf, Saudi Arabia.ORCID 0000-0003-0781-0850
Mohammed GamalPharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Alshaheed Shehata Ahmed Hegazy St., Beni-Suef 62574, Egypt.ORCID 0000-0002-4674-6516
Mohammed M GhoneimDepartment of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Riyadh, Saudi Arabia.ORCID 0000-0002-9179-4373
Lobna Mohammed Abd ElhalimAnalytical Chemistry Department, Central Administration of Drug Control, Egyptian Drug Authority, 51 Wezaret Al Zeraa Street, Agouza, Giza 12311, Egypt.
Alfaisal University · SABeni-Suef University · EGEgyptian Government · EGJouf University · SA

Funding

Al Jouf University DSR-2021-03-0344
6 · The paper itself

Abstract

Combination therapy of many anthelmintic drugs has been used to achieve fast animal curing. Q-DRENCH is an oral suspension, containing four different active drugs against GIT worms in sheep, commonly used in Australia and New Zeeland. The anti-parasitic drugs are Albendazole (ALB), Levamisole HCl (LEV), Abamectin (ABA), and Closantel (CLO). The main purpose of this study is to present a new simultaneous stability-indicting HPLC-DAD method for the analysis of the four drugs. The recommended liquid system was 1 mL of Triethylamine/L water, adjusting the pH to 3.5 by glacial acetic acid: acetonitrile solvent (20:80,

Indexed as

Administration, OralAlbendazoleAnimalsAnthelminticsAustraliaChromatography, High Pressure LiquidDrug StabilityEvaluation Studies as TopicIvermectinLevamisoleLimit of DetectionNew ZealandSalicylanilidesSheepSuspensionsabamectinAlbendazoleAnthelminticsclosantelIvermectinLevamisoleSalicylanilidesSuspensionsAbamectinAlbendazoleanti-parasitic drugsClosantelHPLCLevamisole HClQ-DRENCH suspensionstability study

Identifiers

PMID35164028
PMCPMC8839283
OpenAlexW4210415418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.